Day: May 18, 2020

Outlines Actions Taken in Response to COVID-19Receives Notice from NYSEDAVENPORT, Iowa, May 18, 2020 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NYSE: LEE) (“Lee” or the “Company”) today provided a business update, including actions taken in response to the COVID-19 pandemic, and announced that the Company has received a letter from the New York Stock Exchange (NYSE) indicating that the Company is not compliant with certain listing standards.Kevin Mowbray, President and Chief Executive Officer, said, “We have taken swift business and operational actions in the face of the unprecedented COVID-19 pandemic, with a focus – above all else – on protecting the health and safety of our employees, readers and communities. Like other local media companies, we expect our advertising revenue to be significantly impacted by the ongoing...

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — Sequential Brands Group, Inc. (“Sequential” or the “Company”) (NASDAQ:SQBG) announced today that, due to the public health impact of COVID-19 and the uncertainty of using the Company’s facilities, the Company will hold its 2020 Annual Meeting of Stockholders in a virtual meeting format only, via audio webcast.  The date and time of the meeting and the proposals to be presented to stockholders at the meeting are unchanged.  The meeting webcast will be held on Friday, June 5, 2020 at 10:00 a.m. Eastern Time.Attending the Virtual Meeting as a Registered StockholderRegistered holders of the Company’s common stock as of April 9, 2020, can attend, vote and ask questions at the meeting by accessing the meeting center site at www.meetingcenter.io/237191399 and entering the...

Story Had 40+ Errors, Ignored Facts Handed to Reporter Prior to BroadcastNBC News Never Intended to Tell the Truth, Suit ClaimsNASHVILLE, Tenn., May 18, 2020 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (NASDAQ: SDC) the oral care company and first direct-to-consumer medtech platform for teeth straightening, announced today that it has filed a lawsuit seeking approximately $2.8 billion from NBC Universal Media (“NBC”) and reporter Vicky Nguyen for knowingly and intentionally making factually inaccurate, misleading and defamatory claims about the Company and its platform on an NBC Nightly News with Lester Holt report.NBC’s February 13, 2020 ‘Nightly News’ report contained more than 40 false and misleading statements about SmileDirectClub and the treatment patients receive from the hundreds of board-certified doctors who use the company’s...

SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the first quarter ended March 31, 2020 and provided a business update.Dr. Dennis J. Carlo, President and Chief Executive Officer of Adamis Pharmaceuticals, stated, “We are pleased to have resubmitted our ZIMHI New Drug Application to the FDA to get us back on track for regulatory review. We are also very excited to be partnering with US WorldMeds to commercialize both our SYMJEPI and ZIMHI products here in the U.S. Certainly, Adamis has been negatively affected by the COVID-19 outbreak and the various degrees of lockdowns, and it remains to be seen how quickly everyone can get back to a new normal. However, we continue to operate and progress on a number of objectives. We will continue these efforts...

ATLANTA, May 18, 2020 (GLOBE NEWSWIRE) — On May 15, 2020, at its regular quarterly meeting, the Board of Directors of Crawford & Company declared a quarterly dividend of $0.03 per share on the Class A Common Stock and $0.03 per share on the Class B Common Stock, payable on June 12, 2020, to shareholders of record as of the close of business on June 2, 2020. The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock than on the voting Class B Common Stock, subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of Class A Common Stock must receive the same type and amount of consideration as holders of Class B Common Stock, unless different consideration...

VANCOUVER, British Columbia, May 18, 2020 (GLOBE NEWSWIRE) — NuLegacy Gold Corporation (“NuLegacy” or the “Company”) (TSXV: NUG; OTCQB: NULG.F) announces that it has arranged a non-brokered private placement of up to 75,000,000 units (the “Units”) at a price of C$0.075 per Unit to raise gross proceeds to the Company of C$5.625 million (the “Offering”).Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one transferable Common Share purchase warrant (each full warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one Common Share of the Company at an exercise price of C$0.125 for a period, subject to acceleration, of 24 months following closing of the Offering.NuLegacy’s CEO Albert Matter comments that “Our recent winter 2019 drill program and subsequent analysis and geological...

Rochester Hills, Michigan, May 18, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer and Barry Steele, Chief Financial Officer, will present at the Lytham Partners Virtual Investor Conference on Wednesday, May 20, 2020 at 1:00 p.m. ET.A webcast of the presentation will be posted under the investor relations section of InfuSystem’s website at www.infusystem.com or can be accessed at https://www.webcaster4.com/Webcast/Page/1698/34757. A replay of the presentation will be available following the event.Management will also be participating in virtual one-on-one meetings...

DALLAS, May 18, 2020 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) (the “Company”), an owner and operator of entertainment and dining venues, announced today that, in connection with its previously announced sale of 9,578,545 shares of its common stock (the “Offering”) to Jefferies LLC (“Jefferies”) pursuant to an underwriting agreement entered into between the Company and Jefferies on May 4, 2020 (the “Underwriting Agreement”), Jefferies has exercised its over-allotment option granted pursuant to the Underwriting Agreement in part to purchase an additional 1,014,871 shares at a price of $10.44 per share. The issuance of the additional shares is expected to occur on May 20, 2020 at which time the Company will have received gross proceeds of approximately $110.6 million for the Offering to date, including...

SPARTA, N.J., May 18, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced that at its special meeting of stockholders, held May 15, 2020, the stockholders approved the issuance of more than 20% of the Company’s common stock pursuant to a private placement transaction with certain accredited investors and a change of control for purposes of NASDAQ Listing Rule 5635. Upon this stockholder approval, on May 15, 2020, the Company completed the $8 million convertible preferred stock financing by investment funds affiliated with Park...

In vivo preclinical data show that Chimeric AutoAntibody Receptor (CAAR) T cells were able to specifically recognize and eliminate anti-MuSK antibody-expressing B cells while sparing control B cellsPHILADELPHIA, May 18, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that in vivo data demonstrating specific engagement and elimination of anti-muscle-specific tyrosine kinase (MuSK) antibody-expressing target cells by Chimeric AutoAntibody Receptor (CAAR) T cells was presented at the American Academy of Neurology (AAN) 2020 Science Highlights Virtual Platform by the laboratory of Aimee Payne, M.D., Ph.D., Associate Professor of Dermatology in...